Browse our complete database | AME

All filters

Abstracts

Low muscle mass is the body composition parameter most predictive of pre-frailty and frailty in Asians living with HIV

Presented at:

APACC 2019

Abstracts

Predictive effect of Body Mass Index on Immune Reconstitution among HIV-Infected HAART Users in China

Presented at:

APACC 2019

Abstracts

Pharmacoeconomic evaluation of JULUCA (DTG/RPV) for human immunodeficiency virus (HIV-1) infection treatment in virologically-supressed adults in Taiwan.

Presented at:

APACC 2019

Abstracts

Weight-based ART regimens in adults can achieve viral suppression and save costs

Presented at:

APACC 2019

Abstracts

Impact of point-of-care pharmacist counseling at late refills of antiretroviral therapy: A Study Following the Early Warning Indicators of World Health Organization Recommendations

Presented at:

APACC 2019

Abstracts

Raltigravir was non-superior to Lopinavir/ritonavir for treatment-experienced Chinese patients with HIV-1 infection: a 48-week randomized multicenter control study

Presented at:

APACC 2019

Abstracts

Evolution of weight and lipid profiles in HIV-positive patients switched to coformulated elvitegravir/ cobicistat/emtricitabine/ tenofovir alafenamide

Presented at:

APACC 2019

Abstracts

Low prevalence of HLA-B5701 and abacavir intolerance in HLA-B5701 negative Thais with acute HIV infection

Presented at:

APACC 2019

Abstracts

The efficacy and safety of two-drug regimen including dolutegravir plus a boosted protease inhibitor in highly experienced HIV-infected patients

Presented at:

APACC 2019

Abstracts

Effectiveness and Tolerability of Switch of Combination Antiretroviral Therapy to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide among HIV-Positive Taiwanese

Presented at:

APACC 2019

Abstracts

Efficacy and Safety of Doravirine in Treatment-Naïve Asian Adults with HIV-1

Presented at:

APACC 2019

Abstracts

Six-year Immunologic Recovery and Virological Suppression of LPV/r-based Second-line Antiretroviral among HIV Patients: A Multi-center Real-world Cohort Study in China

Presented at:

APACC 2019

Abstracts

Efficacy of dolutegravir (DTG) plus lamivudine (3TC) versus DTG plus tenofovir/emtricitabine (TDF/FTC) in antiretroviral treatment-naive adults with HIV-1 infection: 48-week subgroup results from the GEMINI studies in participants from Asian centers

Presented at:

APACC 2019

Abstracts

Predictors of long-term survival in the TREAT Asia HIV Observational Database Low Intensity TransfEr (TAHOD-LITE)

Presented at:

APACC 2019

Abstracts

The impact of antiretroviral drug resistance in Taiwanese HIV-1-infected MSM population between 2015 and 2018

Presented at:

APACC 2019

Abstracts

Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in Bangkok

Presented at:

APACC 2019

Abstracts

Genotypic Resistance to Integrase inhibitor: a cross sectional study during 2014-2018 in Bangkok, Thailand

Presented at:

APACC 2019

Abstracts

Transmitted Drug Resistance to Rilpivirine among Antiretroviral-naïve People Living with HIV in Central Taiwan

Presented at:

APACC 2019

Abstracts

Virologic failure and HIV drug resistance on second line antiretroviral therapy among adults living with HIV in the Asia-Pacific

Presented at:

APACC 2019

Abstracts

Use and outcomes of antiretroviral monotherapy and treatment interruption in perinatally HIV-infected adolescents in Asia

Presented at:

APACC 2019

Abstracts

Enhanced ART Retention Strategy and Outcomes in 11 Provinces of Vietnam

Presented at:

APACC 2019

Abstracts

Differentiated care delivery through Telemedicine for PLHIV in the Philippines

Presented at:

APACC 2019

Abstracts

A dual analysis of loss to follow-up for perinatally HIV-infected adolescents receiving combination antiretroviral therapy in Asia

Presented at:

APACC 2019

Abstracts

Back To ART (B2A) Initiative in Yunnan Province, China

Presented at:

APACC 2019